Table 4:

Characteristics and quality of included guidelines and position statements (review 3)

Organization, yearDocument typeCountryAppraisal of Guidelines for Research & Evaluation II domain scores, %*
Scope and purposeStakeholder involvementRigor of developmentClarity of presentationApplicabilityEditorial independence
Canadian Cancer Society, 2017 (24)Position statementCanadaNANANANANANA
Canadian Cancer Society, 2017 (25)Position statementCanadaNANANANANANA
Centre of Excellence for Transgender Health, 2016 (26)GuidelineUnited States81562981270
International Planned Parenthood Federation, 2015 (27)Position statementUnited KingdomNANANANANANA
Sherbourne Health Centre, 2015 (28)GuidelineCanada6444162560
Transgender Health Information Program, 2015 (5)GuidelineCanada6767614130
Centers for Disease Control and Prevention, 2013 (29)Position statementUnited StatesNANANANANANA
National Health Service, 2013 (30)GuidelineUnited Kingdom6425028170
American College of Obstetricians and Gynecologists, 2011 (31)Position statementUnited StatesNANANANANANA
Endocrine Society, 2009 (32)GuidelineUnited States72336358846
Vancouver Coastal Health, Transcend Transgender Support & Education Society and Canadian Rainbow Health Coalition, 2006 (4)GuidelineCanada8661178900
  • Note: NA = not assessed.

  • * We did not assess the quality of position statements as they are unlikely to undergo the same development process as guidelines.